Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,198.7
-15.0 (-0.47%)

 

  • STI Straits Times Index
    3,198.7
    -15.0 (-0.47%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,535.0
    0.8 (0.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,609.2
    -46.7 (-0.17%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,030.2
    54.8 (1.84%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,479.2
    78.5 (0.34%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,942.5
    13.7 (0.23%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,239.6M
  • Value: 1,113.8M
  • Rise: 156
  • Fall: 146
  • Unch: 512

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AusGroup^0.052-
IPS Securex0.072-
OEL0.029-
YZJ Shipbldg SGD1.040+0.020
ESR-REIT0.550+0.005
Tritech0.023-
SunMoonFood^0.048+0.003
Sino Grandness0.032+0.003
Sen Yue0.031+0.005
Singtel3.130-0.040

World Indices

World Indices
Name Last Change
Nasdaq 9,817.2 +84.4
HSI 27,609.2 -46.6
HSCEI 10,914.0 +5.4
Jakarta 5,942.5 +13.7
Nikkei 225 23,479.2 +78.5
SSE Comp 3,030.2 +54.8
Shanghai A 3,175.4 +57.4
Shanghai B 244.1 +4.7
KOSPI 2,195.5 -14.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CELLDEX THERAPEUTICS INC CELLDEX THERAPEUTICS
Updated on 19 Feb 2020 (End of trading day)
Last (USD): 2.230 Change: -0.070 High: 2.295 Remarks: -
Change (%): -3.04 Low: 2.210
Open 2.290 Yesterday's Close 2.3
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 114,158 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -9.04589 Trailing EPS (USD) e -2.98169 NAV (USD) b 6.0659
PE a - Trailing PE f - Price / NAV b 0.3676
Dividend (USD) d - Cash In Hand (USD) g 0.9924 Issued & Paid-up Shares c 16,713,000
Dividend Yield (%) d - Price / Cash In Hand g 2.247 Treasury Shares h -
Beta - 75 Daysi 0.646 R-Squared - 75 Days(%)i 1.26 Market Cap (M) 37.270
Beta - 500 Daysi -2.166 R-Squared - 500 Days (%)i 0.26 Enterprise Value (M) -31.713
Piotroski F Score 2 Exchange Code CLDX Par Value ( $ ) n.a.
52 Weeks Volatility (%) 46.38 Free Float (%) 99.8
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 Dec 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CELLDEX THERAPEUTICS INC NASDAQ 37.270 - - 0.3676 -
Industry Medical Specialties NASDAQ 2,190.779 - 241.910 7.9213 0.042
Local Peer INTUITIVE SURGICAL INC NASDAQ 71,316.242 63.229 51.705 8.6300 -
Local Peer DEXCOM INC NASDAQ 26,716.138 - 264.272 30.2717 -
Local Peer IDEXX LABORATORIES INC NASDAQ 24,828.470 65.853 58.357 140.6400 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 21,843.023 54.575 49.332 16.2261 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 15,787.195 67.752 68.260 8.6393 -
Local Peer HOLOGIC INC NASDAQ 13,944.474 - 56.387 6.1953 -
Local Peer INSULET CORPORATION NASDAQ 13,333.151 4,050.141 806.847 88.5527 -
Local Peer DENTSPLY SIRONA INC NASDAQ 13,031.236 - 80.242 2.5767 0.599
Local Peer MASIMO CORPORATION NASDAQ 9,769.533 50.477 51.357 8.8144 -
Local Peer NOVOCURE LTD NASDAQ 9,476.282 - - 49.7790 -
Local Peer BRUKER CORPORATION NASDAQ 7,698.060 42.839 37.243 9.1080 0.326
Local Peer ABIOMED INC NASDAQ 7,566.078 29.211 30.860 7.2274 -
Other Local Peers TANDEM DIABETES CARE INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), NUVASIVE INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), NEOGEN CORP (NASDAQ), QUIDEL CORP (NASDAQ), LIVANOVA PLC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), BIOTELEMETRY INC (NASDAQ), ATRICURE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), ATRION CORP (NASDAQ), INMODE LTD (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CAREDX INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), INOGEN INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), CERUS CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), HESKA CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), QUOTIENT LTD (NASDAQ), AXOGEN INC (NASDAQ), SI BONE INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), SURMODICS INC (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), CUTERA INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), ZYNEX INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), IRADIMED CORP (NASDAQ), MISONIX INC (NASDAQ), SIENTRA INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), PROFOUND MED CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SOLITON INC (NASDAQ), TELA BIO INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), DERMTECH INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), INTRICOM CORP (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), FONAR CORP (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), PAVMED INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), NEPHROS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), CONFORMIS INC (NASDAQ), NEURONETICS INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IRIDEX CORP (NASDAQ), IMMUCELL CORP (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), ELECTROCORE INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), CELSION CORPORATION (NASDAQ), NEOVASC INC (NASDAQ), BIOMERICA INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), BIOLASE INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), NEUROTROPE INC (NASDAQ), ENDOLOGIX INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), CYANOTECH CORP (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), AVINGER INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), DYNATRONICS CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), CANCER GENETICS INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), DIGIRAD CORP (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), NEUROMETRIX INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 157,934.864 67.121 43.022 - 1.289
Global Peer MEDTRONIC PLC NYSE 152,495.033 32.929 44.851 - 1.829
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 136,232.682 46.369 36.859 4.5908 0.215
Global Peer DANAHER CORP NYSE 113,999.405 43.004 38.778 3.9761 0.394
Global Peer STRYKER CORP NYSE 84,316.833 23.731 40.479 6.5837 0.857
Global Peer BECTON DICKINSON & CO NYSE 69,439.270 - 92.958 3.2754 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 59,962.136 35.884 12.758 - -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 49,078.607 67.957 46.880 11.8310 -
Global Peer BAXTER INTERNATIONAL INC NYSE 47,563.397 29.288 30.065 6.0885 0.787
Global Peer ZIMMER BIOMET HOLDINGS INC NYSE 32,913.554 - 29.086 2.6559 0.595
Other Global Peers RESMED INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), STERIS PLC (NYSE), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), COCHLEAR LTD (ASX), FISHER & PAYKEL HEALTHCARE CORP (ASX), QIAGEN NV (NYSE), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), HAEMONETICS CORP (NYSE), WEIGAO GROUP (HKEx), GLOBUS MED INC (NYSE), HARTA (Bursa), ENVISTA HOLDINGS CORPORATION (NYSE), NEVRO CORP (NYSE), Top Glove (SGX), TOPGLOV (Bursa), CONMED CORP (NYSE), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), EBOS GROUP (ASX), AK MEDICAL (HKEx), MICROPORT (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), VENUS MEDTECH-B (HKEx), CRYOLIFE INC (NYSE), CIRC (HKEx), LIFETECH SCI (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), SUPERMX (Bursa), MEDICAL DEVELOPMENT INTL (ASX), YESTAR HEALTH (HKEx), MCP INCOME OPPORTUNITIES TRUST (ASX), CORMEDIX INC (NYSE American), INVACARE CORP (NYSE), STEREOTAXIS INC (NYSE American), GOLDEN MEDITECH (HKEx), PW MEDTECH (HKEx), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), KDL MEDICAL (HKEx), VAPOTHERM INC (NYSE), MODERN DENTAL (HKEx), SOMNOMED LIMITED (ASX), RESAPP HEALTH LIMITED (ASX), COMPUMEDICS (ASX), ELECTROMED INC (NYSE American), YUNNAN ENERGY (HKEx), MILESTONE SCIENTIFIC INC (NYSE American), ONCOCYTE CORP (NYSE American), SDI LTD (ASX), ELLEX MEDICAL LASERS LTD (ASX), ALPHA PRO TECH (NYSE American), KELFRED (HKEx), VINCENT MED (HKEx), CYCLOPHARM LIMITED (ASX), RESONANCE HEALTH LTD (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), OVENTUS MEDICAL LTD (ASX), EMVISION MEDICAL DEVICES LTD (ASX), Biolidics (SGX), Medtecs Intl (SGX), DAXOR CORP (NYSE American), IMPEDIMED LIMITED (ASX), UG Healthcare (SGX), USCOM LTD (ASX), Yunnan Energy (SGX), MICRO-X LTD (ASX), RESPIRI LTD (ASX), LIFE HEALTHCARE (HKEx), IMPRESSION HEALTHCARE LIMITED (ASX), RA MEDICAL SYSTEMS INC (NYSE), LBT INNOVATIONS LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), LKL (Bursa), DIMERIX LTD (ASX), CARDIEX LTD (ASX), Annica (SGX), OPTISCAN IMAGING (ASX), ADHERIUM LIMITED (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), INSPIREMD INC (NYSE American), MICRON SOLUTIONS INC (NYSE American), ALLEGRA ORTHOPAEDICS LIMITED (ASX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DORSAVI LTD (ASX), METALICITY LIMITED (ASX), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.080
-3.46 %
10 Days --0.150
-6.30 %
20 Days --0.100
-4.29 %
Medium Term Return 3 Months -+0.010
+0.45 %
6 Months --0.200
-8.23 %
1 Year --3.760
-62.77 %
Long Term Return 2 Years --33.170
-93.70 %
3 Years --46.670
-95.44 %
5 Years --371.870
-99.40 %
Annualised Return Annualised --
-64.10 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 2.010 - 6.430 Change From 1 Year Low +0.220 % Change From 1 Year Low (%) +10.95
Change From 1 Year High -4.200 % Change From 1 Year High (%) -65.32
2 Years Range 2.010 - 42.900 Change From 2 Years Low +0.220 % Change From 2 Years Low (%) +10.95
Change From 2 Years High -40.670 % Change From 2 Years High (%) -94.80
5 Years Range 2.010 - 492.300 Change From 5 Years Low +0.220 % Change From 5 Years Low (%) +10.95
Change From 5 Years High -490.070 % Change From 5 Years High (%) -99.55
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Celldex Therapeutics, Inc. engages in the research, development, and commercialization of immunotherapies and other targeted biologics. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Historical Price Data

Date Open High Low Close Volume VWAP
19 Feb 2020 2.290 2.295 2.210 2.230 114,158 -
18 Feb 2020 2.290 2.320 2.210 2.300 157,042 -
14 Feb 2020 2.340 2.340 2.260 2.280 92,294 -
13 Feb 2020 2.250 2.310 2.230 2.310 84,423 -
12 Feb 2020 2.310 2.330 2.240 2.260 63,861 -
11 Feb 2020 2.310 2.320 2.260 2.300 42,958 -
10 Feb 2020 2.310 2.350 2.260 2.280 54,891 -
07 Feb 2020 2.380 2.380 2.280 2.310 107,524 -
06 Feb 2020 2.350 2.430 2.320 2.380 109,400 -
05 Feb 2020 2.370 2.454 2.350 2.360 77,636 -
04 Feb 2020 2.270 2.405 2.270 2.370 84,930 -
03 Feb 2020 2.330 2.350 2.260 2.260 65,861 -
31 Jan 2020 2.310 2.340 2.250 2.315 82,370 -
30 Jan 2020 2.370 2.383 2.300 2.310 128,268 -
29 Jan 2020 2.380 2.390 2.340 2.390 106,996 -
28 Jan 2020 2.250 2.350 2.240 2.340 92,287 -
27 Jan 2020 2.280 2.280 2.220 2.250 104,906 -
24 Jan 2020 2.330 2.400 2.250 2.290 111,965 -
23 Jan 2020 2.290 2.360 2.273 2.330 96,177 -
22 Jan 2020 2.330 2.360 2.270 2.290 224,628 -
21 Jan 2020 2.420 2.438 2.300 2.330 204,593 -
17 Jan 2020 2.510 2.580 2.430 2.450 97,983 -
Summary
Current 2 Weeks
(05 Feb 2020 to 19 Feb 2020)
2.370 2.454 2.210 2.230 904,187 -
Previous 2 Weeks
(22 Jan 2020 to 04 Feb 2020)
2.330 2.454 2.210 2.370 1,098,388 -
4 Weeks from
(20 Dec 2019 to 21 Jan 2020)
2.260 2.454 2.210 2.330 3,309,124 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.